First patients in UMC Utrecht treated with new technique for heart rhythm disorders
UMC Utrecht, along with three other centers in Europe, successfully treated the first patients with severe cardiac arrhythmias worldwide with Abbott’s new ablation system. This new technique uses extremely short electrical pulses instead of heating or freezing heart tissue. For patients with atrial fibrillation, this technique is safer, more effective and faster. This promising treatment is now expected to be used increasingly in Europe for patients with cardiac arrhythmias.
Atrial fibrillation is the most common cardiac arrhythmia worldwide. In patients with atrial fibrillation, the electrical excitation and conduction in the atria of the heart is disturbed. At UMC Utrecht, together with Abbott, a new ablation system (VoltTM PFA) has been developed with which atrial fibrillation can be surgically treated. This technique consists of a newly developed balloon catheter and uses short electrical pulses (Pulsed Field Ablation). With this, the cardiologist switches off the part of the heart that is causing the arrhythmia. This is done through a tube inserted into the heart through a blood vessel.
Promising new treatment technique
UMC Utrecht is one of the first hospitals in Europe to use the new treatment technique. In total, the first sixteen patients with atrial fibrillation in four centers in the Netherlands, Austria, Germany and Belgium have now been treated with this technique. “It is one of the most startling techniques in electrophysiology, a real game changer,” said Peter Loh, cardiologist-electrophysiologist at UMC Utrecht. “The expectation is that this promising treatment will now be increasingly used in Europe for patients with atrial fibrillation.”
Treatment safer, more effective and faster
Scientific studies show that the treatment is safe and effective for patients with atrial fibrillation. Peter Loh: “Because the electric pulse is ultra-short, essentially no heat is created and, as a result, patients experience few side effects. The treatment is safe and could take place within an hour. This is faster than standard ablation treatment by heating heart tissue, which usually takes two to three hours. The shorter surgery time will likely allow us to offer treatment to more patients.”
Probability of arrhythmia recurrence expected to be reduced
The new treatment technique allows cardiologists to treat the right spots in the heart precisely and effectively. Peter Loh: “We also expect long-term results to improve with the new VoltTM PFA ablation system. After treatment with the existing techniques, about thirty percent of patients develop atrial fibrillation again and often have to undergo a second ablation. With the new system that uses a balloon catheter, the chance of the arrhythmia returning is expected to be reduced, future research will show.”
Eight million Europeans
An estimated eight million Europeans over the age of 65 are currently living with atrial fibrillation. This number is expected to double within 30 years. In the Netherlands, more than 400,000 people have atrial fibrillation. In addition, there are an estimated 80,000 people with atrial fibrillation who do not know because they have never been diagnosed. Atrial fibrillation increases the risk of stroke, heart failure and death.
31 May running festival at Utrecht Science Park; read all about accessibility
On Sunday 31 May 2026, Utrecht will once again be fully dedicated to the HiPRO Utrecht Marathon supported by Utrecht Science Park. With a large amount of participants in the previous edition, the event has grown into a staple for runners from Utrecht and far beyond. This year also promises to be a special edition, featuring the new addition of the Dutch National Championships Half Marathon (NK Halve Marathon). Utrecht Science Park will once again be the vibrant heart of the event, where sport, energy, and connection come together.
Jan Henk van der Velden leaves Utrecht Science Park Foundation and becomes the new Managing Director at Utrechtse Heuvelrug National Park
After nine years, Jan Henk van der Velden will step down as Managing Director of the Utrecht Science Park Foundation effective this coming July 1. As of September 1, 2026, Jan Henk will become Managing Director of the Utrechtse Heuvelrug National Park Foundation. He announced his departure several months ago.
UMC Utrecht takes third surgical robot into use
UMC Utrecht has commissioned a third surgical robot. With the arrival of the latest generation, the Da Vinci 5, even more patients can be operated on with minimal stress. This leads to fewer complications and faster recovery. “Apart from the benefits for patients, the Da Vinci 5 also allows us to train even better,” says Jelle Ruurda, gastrointestinal surgeon and professor of robot-assisted minimally invasive surgery. “At the touch of a button, colleagues can watch remotely, and even learn from previous operations. This way we share knowledge faster and more widely.” The hospital is thus building on a tradition of 25 years at the forefront of robotic surgery.
Inspiring and connecting visit by the President of Estonia to Utrecht Science Park
On Wednesday, April 8, 2026, the President of Estonia, Mr. Alar Karis, together with his wife Sirje Karis, ambassador Mr. Paul Teesalu and a delegation from the Estonian Health Ecosystem, visited the Utrecht Science Park. During the visit, much knowledge was exchanged and valuable connections were made.